PHAXIAM Therapeutics S.A.
DelistedCIK 1624422fmd_11MVWT1HSSYES82Y6QDPX6ZQX6Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2015 to Jun 30, 2023, 14 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Operating income
- (3)
- Net income
- (0)
- Free cash flow
- (32)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- -43.5%
- Revenue, 5 yearsFY2017 to FY2022
- +1.7%
- Net income, 5 yearsFY2017 to FY2022
- n/m
PHAXIAM Therapeutics S.A. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | €194,000 | €128,000 | +51.6% | 20-F 2023-03-28 · proof |
| Operating income | -€2.8 million | -€56.5 million | 20-F 2023-03-28 · proof | |
| Net income | -€228,000 | -€53.8 million | 20-F 2023-03-28 · proof | |
| Cash from operating activities | -€31.8 million | -€56.8 million | 20-F 2023-03-28 · proof | |
| Free cash flow | -€31.8 million | -€57.1 million | 20-F 2023-03-28 · proof | |
| Total assets | €45.8 million | €66.8 million | -31.4% | 20-F 2023-03-28 · proof |
| Total liabilities | €22.3 million | €43.9 million | -49.2% | 20-F 2023-03-28 · proof |
| Cash and cash equivalents | €38.8 million | €33.7 million | +15.1% | 20-F 2023-03-28 · proof |
| Total debt | €10.1 million | €15.4 million | -34.3% | 20-F 2023-03-28 · proof |
- What was PHAXIAM Therapeutics S.A.'s revenue in fiscal 2022?
- PHAXIAM Therapeutics S.A. reported revenue of €194,000 for fiscal 2022 (the year ended Dec 31, 2022), against €128,000 the year before (+51.6%). Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
- What was PHAXIAM Therapeutics S.A.'s operating income in fiscal 2022?
- PHAXIAM Therapeutics S.A. reported operating income of -€2.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -€56.5 million the year before. Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
- What was PHAXIAM Therapeutics S.A.'s net income in fiscal 2022?
- PHAXIAM Therapeutics S.A. reported net income of -€228,000 for fiscal 2022 (the year ended Dec 31, 2022), against -€53.8 million the year before. Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
- What was PHAXIAM Therapeutics S.A.'s cash from operating activities in fiscal 2022?
- PHAXIAM Therapeutics S.A. reported cash from operating activities of -€31.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -€56.8 million the year before. Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
- What was PHAXIAM Therapeutics S.A.'s free cash flow in fiscal 2022?
- PHAXIAM Therapeutics S.A. reported free cash flow of -€31.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -€57.1 million the year before. Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
- What are PHAXIAM Therapeutics S.A.'s total assets?
- As of Dec 31, 2022, PHAXIAM Therapeutics S.A. reported total assets of €45.8 million, against €66.8 million a year earlier (-31.4%). Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
- What are PHAXIAM Therapeutics S.A.'s total liabilities?
- As of Dec 31, 2022, PHAXIAM Therapeutics S.A. reported total liabilities of €22.3 million, against €43.9 million a year earlier (-49.2%). Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
- What are PHAXIAM Therapeutics S.A.'s cash and cash equivalents?
- As of Dec 31, 2022, PHAXIAM Therapeutics S.A. reported cash and cash equivalents of €38.8 million, against €33.7 million a year earlier (+15.1%). Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
- What is PHAXIAM Therapeutics S.A.'s total debt?
- As of Dec 31, 2022, PHAXIAM Therapeutics S.A. reported total debt of €10.1 million, against €15.4 million a year earlier (-34.3%). Source: the 20-F filed with the SEC on Mar 28, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1624422&period_type=annual&limit=5"Information only, not investment advice.